Immunofluorescence analysis of mouse glioblastoma (Rusu et al, 2019) also confirmed the enrichment of Sox9 and p27-positive cells in TMZ-treated animals (Fig. EV3H). The gene discussed is SOX9; the disease is glioblastoma.